Y.D. Lapierre

3.6k total citations
139 papers, 2.6k citations indexed

About

Y.D. Lapierre is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Y.D. Lapierre has authored 139 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Psychiatry and Mental health, 38 papers in Cellular and Molecular Neuroscience and 34 papers in Pharmacology. Recurrent topics in Y.D. Lapierre's work include Treatment of Major Depression (31 papers), Bipolar Disorder and Treatment (30 papers) and Neurotransmitter Receptor Influence on Behavior (26 papers). Y.D. Lapierre is often cited by papers focused on Treatment of Major Depression (31 papers), Bipolar Disorder and Treatment (30 papers) and Neurotransmitter Receptor Influence on Behavior (26 papers). Y.D. Lapierre collaborates with scholars based in Canada, United States and Belgium. Y.D. Lapierre's co-authors include David Bakish, Pavel D. Hrdina, R.B. Rastogi, Radhey L. Singhal, Arun Ravindran, Verner Knott, Lisheng Du, Jerzy Chudzik, Robert J. Bialik and Brent Waters and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Neurochemistry.

In The Last Decade

Y.D. Lapierre

137 papers receiving 2.5k citations

Peers

Countries citing papers authored by Y.D. Lapierre

Since Specialization

Citations

This map shows the geographic impact of Y.D. Lapierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.D. Lapierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.D. Lapierre more than expected).

Fields of papers citing papers by Y.D. Lapierre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y.D. Lapierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.D. Lapierre. The network helps show where Y.D. Lapierre may publish in the future.

Co-authorship network of co-authors of Y.D. Lapierre

This figure shows the co-authorship network connecting the top 25 collaborators of Y.D. Lapierre. A scholar is included among the top collaborators of Y.D. Lapierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y.D. Lapierre. Y.D. Lapierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serotonin and Dopamine Antagonism in Obsessive-Compulsive Disorder: Effect of Atypical Antipsychotic Drugs 2000 ·Pharmacopsychiatry ·Rajamannar Ramasubbu, Arun Ravindran, Y.D. Lapierre	57
2	The treatment of negative symptoms: a clinical and methodological study 1999 ·International Clinical Psychopharmacology ·Y.D. Lapierre, (unknown), A. George Awad, (unknown), B. Jones, Peter Williamson, Pierre Vincent, (unknown), (unknown), Rahul Manchanda, Benoit R. Gauthier, (unknown), Michael D. Teehan, (unknown), (unknown), L. Kola Oyewumi, Ewald W. Busse, Alain Labelle, L. Claesson, (unknown)	8
3	Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims 1999 ·Biological Psychiatry ·Lisheng Du, Gábor Faludi, Miklós Palkovits, (unknown), David Bakish, Y.D. Lapierre, Péter Sótonyi, Pavel D. Hrdina	142
4	Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression 1999 ·Psychiatry Research ·(unknown), Lisheng Du, David Bakish, Y.D. Lapierre, Pavel D. Hrdina	51
5	Guidelines for depot antipsychotic treatment in schizophrenia 1998 ·European Neuropsychopharmacology ·John M. Kane, Eugenio Aguglia, A. Carlo Altamura, José Luis Gutiérrez, N. Brunello, W. Wolfgang Fleischhacker, W. Gaebel, Jes Gerlach, (unknown), Werner Kissling, Y.D. Lapierre, Eva Lindström, Julien Mendlewicz, Giorgio Racagni, Luis Salvador‐Carulla, Nina R. Schooler	255
6	Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment 1997 ·Psychiatry Research ·Pavel D. Hrdina, David Bakish, (unknown), Jerzy Chudzik, Patrizia Cavazzoni, Y.D. Lapierre	91
7	Alprazolam and amitriptyline in the treatment of moderate depression 1994 ·International Clinical Psychopharmacology ·Y.D. Lapierre, Michael W. Browne, (unknown), (unknown)	10
8	Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatonin 1994 ·Journal of Affective Disorders ·Arun Ravindran, Robert J. Bialik, Gregory M. Brown, Y.D. Lapierre	9
9	Dysthymia and serotonin 1993 ·International Clinical Psychopharmacology ·Y.D. Lapierre, (unknown), David Bakish	3
10	Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines. 1993 ·PubMed ·Alain Labelle, Y.D. Lapierre	2
11	Keratodermia: side effects of lithium. 1991 ·PubMed ·Alain Labelle, Y.D. Lapierre	1
12	Event-related potentials and selective attention in major depressive illness 1991 ·Journal of Affective Disorders ·Verner Knott, Y.D. Lapierre, (unknown), (unknown), David Bakish	12
13	Temporal segmentation of response speed in depression: Neuro-electrophysiological approaches 1991 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Verner Knott, Y.D. Lapierre	5
14	Lithium as an Adjunct in the Treatment of Major Depression 1990 ·International Clinical Psychopharmacology ·Michael W. Browne, Y.D. Lapierre, Pavel D. Hrdina, Eva K. Horn	20
15	Selective dopamine D2 antagonist and prolactin response in acute schizophrenia — Results from remoxipride studies 1990 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·A. George Awad, Y.D. Lapierre, (unknown)	8
16	Trimipramine, the introduction of clinical use for 30 years 1989 ·Drugs ·Y.D. Lapierre	18
17	Antidepressant Plasma Levels and Clinical Response in Depressed Patients Treated with Oxaprotiline and Doxepin 1988 ·International Clinical Psychopharmacology ·Pavel D. Hrdina, Y.D. Lapierre, (unknown), David Bakish, Michael W. Browne	2
18	Neurophysiological correlates of sibling pairs discordant for bipolar affective disorder 1985 ·American Journal of Psychiatry ·Verner Knott, Brent Waters, Y.D. Lapierre, Richard Gray	3
19	Benzodiazepine Effect on Information Processing in Generalized Anxiety Disorder 1983 ·Neuropsychobiology ·Y.D. Lapierre, (unknown), L. Kola Oyewumi	1
20	Minor tranquillizers in somatic disorders. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), William M. McLean, Y.D. Lapierre	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact